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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S371Methods: Subjects were 29 patients (53 knees) with knee OA (mean age
65.3  9.8, range 50 – 80 years, all female, Kellgren-Lawrence (KL)
grades II: 23, III: 12, IV: 18). The anteroposterior radiographs of lower
extremities in standing position and the CT images of knee joints were
all prepared. Femorotibial (FT) joint was divided into 5 regions: medial
femoral condyle (MFC), medial tibial plateau (MTP), lateral femoral
condyle (LFC), lateral tibial plateau (LTP) and subspinous (SS). The
location, number, and size of SBCs were measured in CT. SBCs were
deﬁned as the cysts greater than 2 mm in diameter, occurring in the
region within 10 mm from the joint surface. The alignments of lower
extremity were measured in radiographs: percentage of mechanical
axis (%MA), femorotibial angle (FTA), lateral distal femoral angle (LDFA),
medial proximal tibial angle (MPTA), and joint line convergence angle
(JLCA). Relationship between the number of SBCs and the severity of OA
or alignments of lower extremity was analyzed.
Results: SBCs were detected in 88.5% of knees, 53.8% in MFC; 51.9% in
MTP; 5.8% in LFC; 13.5% in LTP; and 17.3% in SS. The mean number of
SBCs was 2.5 in MFC; 2.1 in MTP; 3.0 in LFC; 1.2 in LTP; 1.6 in SS. The
mean size of SBCs resulted respectively as follows: 2.9 mm in MFC; 3.6
mm inMTP; 3.8 mm in LFC; 3.0 mm in LTP, 5.2 mm in SS. The number of
SBCs in MFC and MTP had a signiﬁcantly positive correlation with KL
grades, FTA and JLCA, and had a signiﬁcantly negative correlationwith %
MA and MPTA. However, there was no correlation in LFC, LTP and SS.
Conclusions: SBCs were frequently detected in patients with knee OA,
and more prevalent in medial FT joint. The incidence in medial FT joint
was affected by the severity of knee OA or varus knee deformity,
although the mean size was small and the number was few. However,
SBCs were present in lateral FT joint and SS, and these were not affected
by the severity of knee OA or varus knee deformity.
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THE ASSOCIATION OF BODY COMPOSITION AND METABOLIC
SYNDROME WITH KNEE OA AND KNEE PAIN IN A KOREAN
COMMUNITY RESIDENTS
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Objectives: Obesity, a major concern of contemporary health care sys-
tem is closely related to both musculoskeletal pain and OA. Recently,
proinﬂammatory effect of obesity, independent of its biomechanical
effect has also been gaining interest in the pathogenesis of OA. In this
study, we sought to delineate the relationship between body compo-
sition parameters and knee OA/knee pain in a Korean community res-
idents. In addition, we tried to examine the inﬂuence of metabolic
syndrome on knee OA/knee pain independent of BMI by assessing the
risk stratiﬁed by body mass index (BMI) and the presence or absence of
metabolic syndrome (MetS)
Methods: Participants were from the population-based Hallym Aging
Study, irrespective of the presence of knee OA or knee pain. Demo-
graphic data was obtained by questionnaire. Knee pain was assessed
using the Western Ontario and McMaster Universities (WOMAC)
Osteoarthritis Index and a 100-mm visual analog scale (VAS). Radio-
graphic evaluations consisted of weight-bearing knee anteroposterior
radiographs. Total body fat mass and total lean mass were measured
with Dual x-ray absorptiometry. Each subject underwent MRI of the
more symptomatic knee or the dominant knee depending on the
symptom presence. MRI scans of the knee were obtained with a 1.5-T
scanner with a phase-array knee coil and were read according to
WORMS grading system.
Result: The mean age of participants (230 men, 274 women) was 70.2
years. Radiographic knee OAwas present in 37.3% of subjects. BMI, total
fat mass, and fat/muscle ratio were all signiﬁcantly and positively cor-
related with knee OA while total lean mass was signiﬁcantly and neg-
atively correlated with it. After adjusting for age, sex, and manual work,
the association remained signiﬁcant only for fat/muscle ratio. The
association between fat/muscle ratio and pain VAS score was signiﬁcant
after adjustment. To analyze the association between metabolic syn-
drome features independent of body mass index, we divided the pop-
ulation into 4 groups, (metabolically non-obese, normal weight
(MNNW), metabolically obese, normal weight (MONW), metabolically
non-obese, obese (MNOB), and metabolically obese, obese(MOOB). ORs
for knee OA was signiﬁcantly higher only among MOOB compared to
MNNWafter adjustment. The severity of knee painwas not signiﬁcantly
associated with any of the 3 subgroups compared to MNNW. Cartilage
degeneration as measured with MRI was signiﬁcantly associated onlyfor BMI after adjustment, and was not signiﬁcantly associated with any
of the 3 subgroups compared to MNNW. Neither any component of the
metabolic syndrome, nor the number of metabolic component was
signiﬁcantly associated with radiographic knee OA, knee pain, or car-
tilage degeneration measured with MR.
Conclusion: These results suggest that aside from BMI, body compo-
sition, speciﬁcally fat/muscle mass ratio may have important implica-
tions for the pathogenesis of knee OA and knee pain, while metabolic
syndrome may not.
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Purpose: Glycosylated proteins are essential components of the extrac-
ellular matrix (ECM) of cartilage and contribute to the maintenance of its
function. A shift from a-2,6- to a-2,3-linked sialic acids of glycoproteins
modiﬁes the binding ability of proteins to substrates inﬂuencing cellular
anchoring and affecting signal transduction. Intriguingly, the predom-
inance of a-2,3-sialylation of chondrocytes glycoproteins was associated
with the pathophysiology of rheumatic diseases including rheumatoid
arthritis (RA) and osteoarthritis (OA). A highly O-glycosylated protein
with a-2,3-sialic acid, involved in the induction of inﬂammation and
tissue repair, is the transmembrane mucin receptor named Podoplanin
(PDPN). The present studyaimed to assess the effect of speciﬁcally targets
a-2-3-sialic acid residues with a lectin-based drug (MASL) on chon-
drocyte dedifferentiation and cartilage breakdown processes.
Methods: For immunoﬂuorescence and immunohistochemistry assays,
in situ cartilage was ﬁxed and frozen immediately using Tissue-Tek O.C.T.
and isopentanol in liquid nitrogen. Primary cells in monolayer culture
were ﬁxed with formaldehyde for optical microscopy assays. 4 mm car-
tilage puncheswere prepared from cartilage explants thatwere cut in the
operating room immediately after surgery and cultured in DMEM with
0.1% FCS. Chondrocyteswere isolated fromarticular cartilage and cultured
in DMEM with 15% FCS. Cell viability was evaluated by the colorimetric
MTT assay. Cell adhesion and grown was assess with ﬁbrinogen-coated
well plates and Wound Healing Assay Kit. Reactive oxygen species levels
were measured by DCFH-DA and by Flow Cytometry. RNA was isolated
with TRIZOL Reagent and analyzed by Real-Time RT-PCR.
Results: The treatment of chondrocytes with 400 and 720 nM of MASL
did not affect cell viability, adhesion or growth. To mimic pathological
conditions, cells and cartilage explants were treated with 5 mg/ml oli-
gomycin. Treatment of chondrocytes with oligomycin did not affect cell
viability but increased ROS levels over 10 fold andMMP3, IL-6 and COX2
mRNA levels over 3–10 folds. The treatment of cells with MASL effec-
tively protected chondrocytes from ROS production when incubated in
the presence of oligomycin. Moreover, oligomycin induced the expres-
sion of inﬂammatory cytokines including IL-6 and COX2, and this
induction was reverted by treatment with nanomolar concentrations of
MASL. 5 mg/ml of oligomycin for 7 days decreased safranin uptake and
disrupted the ECM structure of cartilage punches as evidenced by
ulceration increasing lacunae space. However, the presence of 400 nM
of MASL prevented the cartilage destruction and inhibited COX2 and
MMP3 induction by oligomycin treatment. Immunohistochemistry
assays revealed that OA cartilage contained signiﬁcantly higher levels of
PDPN protein in comparison with cartilage from healthy donors.
Conclusions: This study demonstrates that physiologically relevant
concentrations of MASL protect chondrocytes from detrimental effects
of ROS, inﬂammatory cytokines and MMPs and preserve chondrocyte
phenotype and articular cartilage structure under pathological con-
ditions.
